Why the drug development pipeline is not delivering better medicines

Naci, Huseyin, Carter, Alexander W. and Mossialos, Elias (2015) Why the drug development pipeline is not delivering better medicines. BMJ, 351 . ISSN 1756-1833

Preview

PDF - Accepted Version Download (575Kb) | Preview

• LSE expert's profile
• LSE expert's profile

• Published item via DOI

Abstract

Despite the large number of new medicines entering the market every year, the vast majority offer few clinical advantages for patients over existing alternatives. Governments and pharmaceutical companies share the responsibility for this innovation deficit in the sector.

Item Type:	Article
Official URL:	http://www.bmj.com/thebmj
Additional Information:	© 2015 British Medical Journal Publishing Group
Library of Congress subject classification:	R Medicine > RS Pharmacy and materia medica
Sets:	Research centres and groups > LSE Health
Date Deposited:	29 Oct 2015 11:56
URL:	http://eprints.lse.ac.uk/64220/

Actions (login required)

Record administration - authorised staff only